Business Wire

IL-WEBER

18.11.2021 14:57:06 CET | Business Wire | Press release

Share
Weber Inc. Launches 1952 Ventures LLC and Announces Senior Leadership Appointments and Promotions

Weber Inc . (“Weber” or “the Company”) today announced it has established 1952 Ventures LLC , a new subsidiary that will serve as an accelerator of new growth platforms and brand extensions for Weber in the areas of product, technologies, and partnerships. Troy Shay, Chief Commercial Officer of Weber Inc., has been appointed Chief Executive Officer of 1952 Ventures LLC and Chief Growth Officer of Weber. The Company also announced five additional senior leadership appointments and promotions in its Global Operations and Americas and European Operating Segments.

Troy Shay, Chief Executive Officer, 1952 Ventures LLC and Chief Growth Officer of Weber Inc.

Since joining Weber in 2018, Mr. Shay has led the Company’s Americas business in the U.S., Canada, and Latin America. He has been instrumental in managing several strategic Weber commercial initiatives, resulting in exceptional company growth. In his new position, effective December 1, 2021, Mr. Shay will focus on future business development initiatives for Weber and is responsible for identifying and developing new platforms that expand the Company’s product and brand portfolios globally.

Beau Warren Promoted to President Weber Americas

Effective December 1, 2021, Beau Warren will serve as President Weber Americas, succeeding Mr. Shay. Mr. Warren, who joined Weber in 2019 from Fortune Brands, currently serves as Senior Vice President and General Manager of Weber’s U.S. business, which has shown substantial revenue expansion under his leadership.

Michael Jacobs Appointed Chief Operating Officer of Weber Inc.

Michael Jacobs, Chief Supply Chain Officer, has been appointed to the role of Chief Operating Officer. Mr. Jacobs joined Weber in 2014 and most recently served as Chief Supply Chain Officer, leading the Company’s multi-continent manufacturing footprint and global supply chain. In his new position, Mr. Jacobs will oversee end-to-end operations for Weber, from its innovation engine to manufacturing and its customer-facing supply chain.

Jennifer Bonuso Promoted to Senior Vice President and General Manager, Global Product of Weber Inc.

Jennifer Bonuso will serve as Senior Vice President and General Manager, Global Product. Since joining Weber in 2019 from Honeywell and Whirlpool, Mrs. Bonuso has led the creation and management of an industry-leading new product pipeline.

Hans-Jurgen Herr Appointed President Emeritus and EVP Growth Projects, Weber EMEA

Effective December 1, 2021, Hans-Jürgen Herr, currently President of Weber EMEA, will transition to President Emeritus and EVP Growth Projects as part of a planned multi-year succession process. An 18-year veteran of Weber, Mr. Herr has served as President of Weber EMEA for nine years. Through his tenure as President, he has nearly tripled Weber’s business across the region. In his new role, Mr. Herr will lead several growth projects for the Company and serve in an advisory capacity for Weber’s large and growing EMEA business.

Steffen Hahn, Ph.D., Appointed In-Coming President of Weber EMEA

Dr. Steffen Hahn, currently Senior Vice President Commercial of Weber EMEA, will succeed Mr. Herr as President of Weber EMEA, effective December 1, 2021. Dr. Hahn joined Weber in early 2020 as part of a planned succession strategy. Since joining the Company, he has significantly contributed to accelerating Weber’s growth in EMEA. Before Weber, Dr. Hahn worked across a range of successful consumer business engagements at McKinsey & Company and Procter & Gamble.

“The start of 1952 Ventures along with the appointments and promotions of several senior leaders position us for continued growth and market leadership,” said Chris Scherzinger, Chief Executive Officer of Weber. “I believe a company’s success reflects the talents of its team, and we have the best global team in the business. We’ll leverage the market-leading strength of our people, our iconic brand, and our worldwide reach to drive new growth platforms and innovative ventures with world-class execution.”

“I want to thank Troy, Beau, Mike, Jennifer, Hans, and Steffen for their leadership and commitment to our Weber team members around the world and our loyal consumers and fans. I am delighted each of them will continue to work closely with me to execute our strategic plan and take our cherished brand to new heights,” added Mr. Scherzinger.

ABOUT WEBER INC .

Weber Inc., headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original charcoal grill nearly 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet and electric grills, smokers, and accessories designed to help outdoor cooking enthusiasts discover what’s possible. Earlier this year, the Company acquired June Life Inc., a smart appliance and technology company, to accelerate the development of its Weber Connect® technology and digital products. Weber offers its barbecue grills and accessories, services, and experiences to a passionate community of millions across 78 countries.

Weber Connect® is a registered trademark of Weber-Stephen Products LLC.

FORWARD-LOOKING STATEMENTS

This press release contains various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Weber’s expectations or beliefs concerning future events. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed in the section titled “Risk Factors” in our Registration Statement (Registration No. 333-257824) on Form S-1. Our future results could be affected by a variety of other factors, including uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions of the COVID-19 outbreak, the current, and uncertain future, impact of the COVID-19 outbreak on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), and cash flows and liquidity, risks relating to any unforeseen changes to or effects on liabilities, future capital expenditures, revenues, expenses, earnings, synergies, indebtedness, financial condition, losses and future prospects, the ability to realize the anticipated benefits and synergies from business acquisitions in the amounts and at the times expected, the impact of competitive conditions, the effectiveness of pricing, advertising, and promotional programs; the success of innovation, renovation and new product introductions; the recoverability of the carrying value of goodwill and other intangibles, the success of productivity improvements and business transitions, commodity and energy prices, transportation costs, labor costs, disruptions or inefficiencies in supply chain, the availability of and interest rates on short-term and long-term financing, the levels of spending on systems initiatives, properties, business opportunities, integration of acquired businesses, and other general and administrative costs, changes in consumer behavior and preferences, the effect of U.S. and foreign economic conditions on items such as interest rates, statutory tax rates, currency conversion and availability, legal and regulatory factors including the impact of any product recalls; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio29.4.2026 13:42:00 CEST | Press release

Highlights: Chiesi agreed to acquire KalVista Pharmaceuticals for $27.00 per share in cash, representing an equity consideration of approximately $1.9bnAcquisition adds to Chiesi’s rare immunology portfolio the first oral, on-demand therapy for hereditary angioedema, strengthening Chiesi’s long-term commitment to people living with rare conditionsTransaction expected to close in Q3 2026 Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista Pharmaceuticals, Inc.(“KalVista”) (Nasdaq: KALV), today announced that the companies have entered into a definitive agreement under which Chiesi will acquire KalVista (the “Transaction”). The Transaction was unanimously approved by both Chiesi’s and KalVista’s Boards of Directors and is expected to close in Q3 2026, subject to the satisfaction of customary closing conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202604

Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 13:00:00 CEST | Press release

Award advances SOSA/CMOSS mission system ecosystem and informs future EW fielding decisions Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S

Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 13:00:00 CEST | Press release

Stablecoin settlement pilot sees record growth 50% quarter over quarter, reaching $7B run rate. Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means o

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica

European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye